ArticlePloS one2018
Health services costs for cancer care in Australia: Estimates from the 45 and Up Study.
Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
70 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- A Systematic Review of the Economic Burden of Prostate Cancer: Direct and Indirect Cost Perspectives.PharmacoEconomics · 2026Pooled it
- Delivery of intravenous anti-cancer therapy at home versus in hospital or community settings for adults with cancer.The Cochrane database of systematic reviews · 2025Pooled it
- Lifetime direct healthcare costs of treating colorectal cancer: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care · 2023Pooled it
- Costs of multimorbidity: a systematic review and meta-analyses.BMC medicine · 2022Pooled it
- Trial
- Care to Quit: a stepped wedge cluster randomised controlled trial to implement best practice smoking cessation care in cancer centres.Implementation science : IS · 2021Trial
- Cost of Treating Patients Who Undergo Resection of Colorectal Liver Metastases: An Australian Pilot Study.Asia-Pacific journal of clinical oncology · 2026Article
- Healthcare cost for non-hospital services and pharmaceuticals among breast cancer survivors: an event study.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
- Barriers to screening amongst first-degree female relatives of patients with breast cancer: a qualitative study.BMC women's health · 2026Article
- Out-of-Pocket Costs and Financial Toxicity Associated With the Surgical Management of Oesophageal Cancer.ANZ journal of surgery · 2026Article
- Article
- Preliminary Cost-Effectiveness of Re-Purposing β-Blockers as an Adjunct Treatment for Women with Triple-Negative Breast Cancer.Healthcare (Basel, Switzerland) · 2025Article
- Hospital spending for cancers in Hunan, China during 2017 and 2019.BMC public health · 2025Article
- Exploring the Costs of Hospital and Emergency Department Utilisation in the First Three Years After Diagnosis for Adults Diagnosed With Pancreatic Cancer in Queensland, Australia.Cancer medicine · 2025Article
- End-of-life healthcare use and associated costs for First Nations Australians diagnosed with cancer in Queensland, Australia.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- Cost of Illness Study on Oral Cancer in Australia.Oral diseases · 2025Article
- A Comparison of the Australian Colonoscopy Care Standards to Current Clinical Practice.Health science reports · 2025Article
- Out-of-pocket costs for patients diagnosed with high-grade glioma and their carers.Neuro-oncology practice · 2025Article
- Emerging burden of post-cancer therapy complications on unplanned hospitalisation and costs among Australian cancer patients: a retrospective cohort study over 14 years.Scientific reports · 2025Article
- A cross-case study comparison of Australian metropolitan and regional cancer nurses' experiences of work-related stressors and supports.BMC nursing · 2025Article
10 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCancer care represents a substantial and rapidly rising healthcare cost in Australia. Our aim was to provide accurate population-based estimates of the health services cost of cancer care using large-scale linked patient-level data.
methodsWe analysed data for incident cancers diagnosed 2006-2010 and followed to 2014 among 266,793 eligible participants in the 45 and Up Study. Health system costs included Medicare and pharmaceutical claims, inpatient hospital episodes and emergency department presentations. Costs for cancer cases and matched cancer-free controls were compared, to estimate monthly/annual excess costs of cancer care by cancer type, before and after diagnosis and by phase of care (initial, continuing, terminal). Total costs incurred in 2013 were also estimated for all people diagnosed in Australia 2009-2013.
results7624 participants diagnosed with cancer were matched with up to three controls. The mean excess cost of care per case was AUD$1,622 for the year before diagnosis, $33,944 for the first year post-diagnosis and $8,796 for the second year post-diagnosis, with considerable variation by cancer type. Mean annual cost after the initial treatment phase was $4,474/case and the mean cost for the last year of life was $49,733/case. In 2013 the cost for cancers among people in Australia diagnosed during 2009-2013 was ~$6.3billion (0.4% of Gross Domestic Product; $272 per capita), with the largest costs for colorectal cancer ($1.1billion), breast cancer ($0.8billion), lung cancer ($0.6billion) and prostate cancer ($0.5billion).
conclusionsThe cost of cancer care is substantial and varies by cancer type and time since diagnosis. These findings emphasise the economic importance of effective primary and secondary cancer prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.